Chison Medical Technologies Co., Ltd. (SHA:688358)
China · Delayed Price · Currency is CNY 34.73
-0.22 (-0.63%)
At close: Feb 13, 2026
SHA:688358 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 449.05 | 468.13 | 480.89 | 375.69 | 394.91 | 329.02 |
Other Revenue | 0.57 | 0.57 | 2.95 | 5.16 | 2.9 | 4.07 |
| 449.62 | 468.7 | 483.84 | 380.84 | 397.81 | 333.09 | |
Revenue Growth (YoY) | 1.20% | -3.13% | 27.05% | -4.26% | 19.43% | -9.92% |
Cost of Revenue | 186.86 | 196.94 | 208.34 | 160.6 | 178.89 | 139.21 |
Gross Profit | 262.76 | 271.75 | 275.5 | 220.24 | 218.92 | 193.88 |
Selling, General & Admin | 91.02 | 92.63 | 84.26 | 81.84 | 76.15 | 56.91 |
Research & Development | 74.44 | 79.63 | 77.07 | 77.88 | 72.29 | 55.64 |
Other Operating Expenses | -3.09 | -2.68 | -3.43 | -4.3 | -2.49 | -2.01 |
Operating Expenses | 163.73 | 171.29 | 161.48 | 154.02 | 146.68 | 111.67 |
Operating Income | 99.03 | 100.47 | 114.02 | 66.22 | 72.24 | 82.21 |
Interest Expense | -0.23 | -0.38 | -0.36 | -0.11 | -0.07 | - |
Interest & Investment Income | 38.83 | 37.32 | 29.6 | 16.43 | 19.59 | 27.82 |
Currency Exchange Gain (Loss) | 10.48 | 10.48 | 5.49 | 26.13 | -6.02 | -8.54 |
Other Non Operating Income (Expenses) | -1.36 | -0.63 | -0.38 | -0.38 | -0.37 | -0.27 |
EBT Excluding Unusual Items | 146.74 | 147.26 | 148.36 | 108.29 | 85.37 | 101.22 |
Gain (Loss) on Sale of Investments | -0.22 | 0.17 | 2.93 | -1.37 | 0.43 | - |
Gain (Loss) on Sale of Assets | 5.13 | 4.61 | 2.96 | -0.5 | 30.26 | 0.01 |
Asset Writedown | -1.21 | - | - | -0.51 | -1.59 | - |
Other Unusual Items | 4.01 | 4.8 | 7.94 | 9.22 | 10.08 | 10.28 |
Pretax Income | 154.45 | 156.85 | 162.19 | 115.13 | 124.54 | 111.51 |
Income Tax Expense | 18.43 | 16.34 | 15.71 | 9.29 | 12.07 | 11.88 |
Net Income | 136.02 | 140.51 | 146.48 | 105.84 | 112.47 | 99.64 |
Net Income to Common | 136.02 | 140.51 | 146.48 | 105.84 | 112.47 | 99.64 |
Net Income Growth | 31.47% | -4.08% | 38.40% | -5.89% | 12.88% | -5.23% |
Shares Outstanding (Basic) | 111 | 112 | 110 | 113 | 112 | 112 |
Shares Outstanding (Diluted) | 111 | 112 | 110 | 113 | 112 | 112 |
Shares Change (YoY) | 1.53% | 1.25% | -2.19% | 0.11% | 0.79% | 28.88% |
EPS (Basic) | 1.22 | 1.26 | 1.33 | 0.94 | 1.00 | 0.89 |
EPS (Diluted) | 1.22 | 1.26 | 1.33 | 0.94 | 1.00 | 0.89 |
EPS Growth | 29.49% | -5.26% | 41.49% | -6.00% | 12.00% | -26.47% |
Free Cash Flow | 129.75 | 131.83 | 51.9 | 11.53 | 0.78 | 51.56 |
Free Cash Flow Per Share | 1.16 | 1.18 | 0.47 | 0.10 | 0.01 | 0.46 |
Dividend Per Share | 1.000 | 1.000 | 0.800 | 0.700 | 0.357 | 0.571 |
Dividend Growth | 25.00% | 25.00% | 14.29% | 96.02% | -37.50% | -20.01% |
Gross Margin | 58.44% | 57.98% | 56.94% | 57.83% | 55.03% | 58.21% |
Operating Margin | 22.02% | 21.44% | 23.57% | 17.39% | 18.16% | 24.68% |
Profit Margin | 30.25% | 29.98% | 30.28% | 27.79% | 28.27% | 29.91% |
Free Cash Flow Margin | 28.86% | 28.13% | 10.73% | 3.03% | 0.19% | 15.48% |
EBITDA | 109.99 | 111.73 | 125.68 | 78.3 | 81.53 | 90.4 |
EBITDA Margin | 24.46% | 23.84% | 25.97% | 20.56% | 20.50% | 27.14% |
D&A For EBITDA | 10.96 | 11.26 | 11.66 | 12.07 | 9.29 | 8.19 |
EBIT | 99.03 | 100.47 | 114.02 | 66.22 | 72.24 | 82.21 |
EBIT Margin | 22.02% | 21.44% | 23.57% | 17.39% | 18.16% | 24.68% |
Effective Tax Rate | 11.93% | 10.42% | 9.69% | 8.07% | 9.69% | 10.65% |
Revenue as Reported | 449.62 | 468.7 | 483.84 | 380.84 | 397.81 | 333.09 |
Advertising Expenses | - | 5.27 | 3.38 | 2.64 | 4.1 | 4.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.